Kayothera, Inc. ("Kayothera"), a preclinical therapeutics company developing first-in-class, small molecule inhibitors of the ...
Chili pepper compounds that suppress heat may also help manage pain. If you’ve ever second-guessed a spicy order, take note: a new study has identified molecules that can temper the heat of chili ...
HTRF uses two fluorophores, a donor and an acceptor, to label proteins or other targeted biomolecules. When these ...
MedPage Today on MSN
Novel Drug Shows Hints of Promise for Progressive MS
Vidofludimus calcium currently is being evaluated in relapsing MS in two phase III trials, ENSURE-1 and ENSURE-2. The phase ...
Millipedes aren’t perhaps the world’s most sought-after animals, but in all those legs, there is chemical gold. The humble ...
Patients with recurring prostate cancer who were treated with a new PSMA-targeted radioligand therapy before stereotactic ...
Dr. Peder Myhre: Welcome listeners to this week's issue of Circulation on the Run, the week of September 23. I am Dr. Peder Myhre, Professor of Cardiology at University of Oslo in Norway. Dr. Shirin ...
Mental health: Lupus causes issues with mental health and thinking, due to a cognitive impairment commonly known as “brain ...
The Subject Expert Committee (SEC) functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined ...
Favorable safety profile enables advancement of radiolabeled PentixaTher to fourth of five planned activity dose levels in investigator-initiated PENTILULA Phase 1/2 trial Milestone marks important ...
News-Medical.Net on MSN
Targeting miR-378 could offer a dual-action strategy against osteoporosis
Osteoporosis is a degenerative disease characterized by decreased bone mass and damage to bone microarchitecture, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results